Compare CIGI & MMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CIGI | MMSI |
|---|---|---|
| Founded | 1972 | 1987 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 4.0B |
| IPO Year | 1995 | 1996 |
| Metric | CIGI | MMSI |
|---|---|---|
| Price | $113.78 | $70.58 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 8 |
| Target Price | ★ $176.25 | $100.38 |
| AVG Volume (30 Days) | 287.8K | ★ 657.7K |
| Earning Date | 05-05-2026 | 04-30-2026 |
| Dividend Yield | ★ 0.26% | N/A |
| EPS Growth | N/A | ★ 4.93 |
| EPS | N/A | ★ 2.13 |
| Revenue | N/A | ★ $1,515,906,000.00 |
| Revenue This Year | $17.28 | $8.78 |
| Revenue Next Year | $8.30 | $5.76 |
| P/E Ratio | $57.57 | ★ $33.14 |
| Revenue Growth | N/A | ★ 11.75 |
| 52 Week Low | $95.66 | $66.34 |
| 52 Week High | $171.20 | $99.26 |
| Indicator | CIGI | MMSI |
|---|---|---|
| Relative Strength Index (RSI) | 58.55 | 52.39 |
| Support Level | $97.32 | $66.76 |
| Resistance Level | $121.40 | $71.57 |
| Average True Range (ATR) | 3.82 | 1.84 |
| MACD | 1.89 | 0.69 |
| Stochastic Oscillator | 91.26 | 86.50 |
Colliers International Group Inc provides commercial real estate professional services and investment management to corporate and institutional clients across different countries around the world. Its operating segments are Commercial Real Estate, Engineering and Investment Management. Maximum revenue for the company is generated from its Commercial Real Estate segment, which offers services like transaction and debt finance services, outsourcing in property management, valuation and advisory, loan servicing, and others. Geographically, the company generates maximum revenue from the United States followed by Canada, Euro currency countries, Australia, the United Kingdom, Poland, China, India, and other regions.
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.